According to Stratistics MRC, the Global Regenerative Medicine Market Outlook (2015-2022) Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022. Growing research applications, growing demand in tissue engineering, biomaterials and stem cell therapy systems are some of the factors driving the market growth. However, high cost associated with biomaterials will be a major factor to restrict the market growth. The stem cells application and advancements in nanotechnology will further drive the market over the forecast period.
Global Regenerative Medicine Market, By Technology is segmented into Small Molecules and Biologics, Gene Therapy and Cell Therapy. Gene therapies segment is expected to be the fastest emerging technology due to enormous prospective of gene therapy in minimizing immune rejections, which occur after transplantations. Regenerative gene therapies are developed for various monogenic diseases such as cystic fibrosis, hemophilia, muscular dystrophy, thalassemia, and sickle-cell anemia. Many organizations are investing in new projects that use technologies like iPS cells and 3-D printers. These factors will further boom the market. However, cell therapy segment dominated the market because of intensified cell therapy products and the high success rate of stem cell treatments.
Browse the full report at “Global Regenerative Medicine Market Outlook (2015-2022)
Global Regenerative Medicine Market, By Application is bifurcated into Dermatology, Cardiovascular Disorders, Central Nervous System (CNS), Orthopedic, Dental and Other Applications. Orthopaedic segment contributes towards the highest market share due to higher prevalence of musculoskeletal cases, increase in orthopedic reconstructive surgeries and growing investments in orthopaedic research. Emergence of nanomaterial in wound care, immunomodulation and for peripheral artery diseases from emerging economies will also boost applications market segment. However, the dermatology is anticipated to be one of the fastest growing segments because of proliferation of skin grafting technique. Additionally, some vendors are also developing regenerative plastic surgery products called autologous cultured epidermis, which are used to meet the increasing demand for anti-aging solutions and curing diabetic foot ulcers.
This report also covers trends driving each segment and offers analysis by geography, with key regions such as North America, Europe, Asia Pacific and Rest of the World. Asia-Pacific is the fastest growing market owing to rapidly increasing aging population & healthcare expenditure, rise in consumer awareness, extensive research in regenerative medicines especially in Japan, amiable government policies and growing medical tourism industry in developing countries such as China and India. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market due to high medical reimbursement facilities & technological advancement as well as most of the therapies are in the 3rd phase of clinical trials
Some of the key players in the market include Shire Pharmaceuticals, Advanced Cell Technology, Inc, Genzyme, Athersys, Inc., Kinetic Concepts, Inc., NuVasive Inc., Stem cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc., Mesoblast Ltd., Zimmer Holdings, Inc., Orthofix, DePuy Synthes Inc., Cell Medica and CryoLife.
request for customization, fill in the Inquiry form at Global Regenerative Medicine Market
Corporate Sales Specialist
Email: [email protected]